Dawid Ciechanowicz1, Daniel Kotrych2, Filip Dąbrowski3, Tomasz Mazurek3. 1. Department of Orthopaedics, Traumatology and Musculoskeletal Oncology, Pomeranian Medical University, 71-281 Szczecin, Poland. 2. Department of Orthopaedics, Traumatology and Orthopaedic Oncology, Collegium Medicum University in Zielona Gora, 65-046 Zielona Gora, Poland. 3. Department of Orthopaedics and Traumatology, Faculty of Medicine, Medical University of Gdansk, 80-803 Gdansk, Poland.
Abstract
BACKGROUND: The proper diagnosis and treatment of bone metastases are essential for patient survival. However, several strategies for the treatment are practiced. Therefore, the aim of the study was to analyze what factors influence the choice of a method of treatment. METHODS: An online survey was conducted within the Polish Society of Orthopedics and Traumatology. It consisted of 45 questions and was divided into four main parts: Participant Characteristics, Diagnosis and Qualification, Treatment, and Clinical Cases. RESULTS: A total number of 104 responses were collected. The most frequently chosen methods were: Intramedullary nail (IMN) + Resection + Polymethyl methacrylate (PMMA) (30.47%) and IMN without tumor resection (42.13%), and in third place, modular endoprosthesis (17.25%). The less experienced group of orthopedic surgeons more often (47.5% vs. 39.5%) decided to perform IMN without tumor resection than the more experienced group (p = 0.046). Surgeons from district hospitals less frequently (13.7% vs. 23.1%) would decide to use modular endoprosthesis than surgeons from university hospitals (p = 0.000076). Orthopedists who performed ≥ 11 bone metastases surgeries per year would more often use modular endoprosthesis (34.8% vs. 13.2%) than those who performed ≤ 10 operations per year (p = 0.000114). CONCLUSION: Experience, place of work, and the number of metastasis surgeries performed during a year may influence the choice of treatment method in patients with bone metastases.
BACKGROUND: The proper diagnosis and treatment of bone metastases are essential for patient survival. However, several strategies for the treatment are practiced. Therefore, the aim of the study was to analyze what factors influence the choice of a method of treatment. METHODS: An online survey was conducted within the Polish Society of Orthopedics and Traumatology. It consisted of 45 questions and was divided into four main parts: Participant Characteristics, Diagnosis and Qualification, Treatment, and Clinical Cases. RESULTS: A total number of 104 responses were collected. The most frequently chosen methods were: Intramedullary nail (IMN) + Resection + Polymethyl methacrylate (PMMA) (30.47%) and IMN without tumor resection (42.13%), and in third place, modular endoprosthesis (17.25%). The less experienced group of orthopedic surgeons more often (47.5% vs. 39.5%) decided to perform IMN without tumor resection than the more experienced group (p = 0.046). Surgeons from district hospitals less frequently (13.7% vs. 23.1%) would decide to use modular endoprosthesis than surgeons from university hospitals (p = 0.000076). Orthopedists who performed ≥ 11 bone metastases surgeries per year would more often use modular endoprosthesis (34.8% vs. 13.2%) than those who performed ≤ 10 operations per year (p = 0.000114). CONCLUSION: Experience, place of work, and the number of metastasis surgeries performed during a year may influence the choice of treatment method in patients with bone metastases.
Entities:
Keywords:
bone metastases; bone tumor; diagnosis; orthopedic oncology; survey; trends in treatment
Authors: Leah Drost; Vithusha Ganesh; Bo Angela Wan; Srinivas Raman; Stephanie Chan; Monique Christakis; May Tsao; Elizabeth Barnes; Michael Ford; Joel Finkelstein; Albert Yee; Angela Turner; Henry Lam; Edward Chow Journal: Radiother Oncol Date: 2017-05-22 Impact factor: 6.280
Authors: Hans Roland Dürr; Peter Ernst Müller; Thomas Lenz; Andrea Baur; Volkmar Jansson; Hans Jürgen Refior Journal: Clin Orthop Relat Res Date: 2002-03 Impact factor: 4.176
Authors: J C Weeks; E F Cook; S J O'Day; L M Peterson; N Wenger; D Reding; F E Harrell; P Kussin; N V Dawson; A F Connors; J Lynn; R S Phillips Journal: JAMA Date: 1998-06-03 Impact factor: 56.272